CTC
EBS icon

Central Trust Company’s Emergent Biosolutions EBS Stock Holding History

Central Trust Company’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-75
Closed -$7K – 1201
2021
Q1 		$7K Buy
75
+30
+67% +$3.07K ﹤0.01% 965
2020
Q4 		$4K Buy
45
+10
+29% +$918 ﹤0.01% 989
2020
Q3 		$4K Sell
35
-29
-45% -$3.13K ﹤0.01% 949
2020
Q2 		$5K Hold
64
– – ﹤0.01% 917
2020
Q1 		$4K Sell
64
-40
-38% -$2.31K ﹤0.01% 1002
2019
Q4 		$6K Sell
104
-14
-12% -$759 ﹤0.01% 1025
2019
Q3 		$6K Sell
118
-74
-39% -$3.45K ﹤0.01% 994
2019
Q2 		$8K Buy
192
+40
+26% +$1.92K ﹤0.01% 974
2019
Q1 		$8K Buy
152
+32
+27% +$1.89K ﹤0.01% 936
2018
Q4 		$7K Sell
120
-50
-29% -$3.22K ﹤0.01% 973
2018
Q3 		$11K Sell
170
-30
-15% -$1.75K ﹤0.01% 974
2018
Q2 		$10K Buy
+200
New +$10.4K ﹤0.01% 975
2017
Q1 		– Sell
-30
Closed – – 1157
2016
Q4 		$0 Hold
30
– – ﹤0.01% 1169
2016
Q3 		$0 Sell
30
-1,259
-98% -$36.6K ﹤0.01% 1120
2016
Q2 		$36K Sell
1,289
-97
-7% -$3.8K ﹤0.01% 752
2016
Q1 		$50K Buy
1,386
+135
+11% +$4.77K ﹤0.01% 675
2015
Q4 		$50K Buy
1,251
+587
+88% +$20.5K ﹤0.01% 644
2015
Q3 		$19K Buy
664
+80
+14% +$2.64K ﹤0.01% 844
2015
Q2 		$19K Hold
584
– – ﹤0.01% 861
2015
Q1 		$17K Hold
584
– – ﹤0.01% 869
2014
Q4 		$16K Sell
584
-44
-7% -$1.05K ﹤0.01% 876
2014
Q3 		$13K Buy
+628
New +$14.4K ﹤0.01% 935

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Central Trust Company's EBS Position: Q2 2021 in Review

Central Trust Company sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 75 shares — an estimated $7K sold.

Central Trust Company first reported a position in EBS in Q3 2014 and held it in 22 quarters. The position peaked at $50K in Q1 2016. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

  • Central Trust Company reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
  • Central Trust Company sold 75 Emergent Biosolutions shares in Q2 2021, an estimated $7K.
  • Central Trust Company first reported a position in Emergent Biosolutions in Q3 2014 and held it in 22 quarters.
  • Central Trust Company's Emergent Biosolutions position peaked at $50K in Q1 2016.
  • 290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on Central Trust Company's 13F filing for Q2 2021, filed 23 Jul 2021.